Aurinia Pharmaceuticals' Reverse Merger Round

Aurinia Pharmaceuticals raised a round of funding on February 06, 2013. Investors include Isotechnika Pharma.

Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. We are currently developing voclosporin, an inves…

Articles about Aurinia Pharmaceuticals' Reverse Merger Round: